Liu S X, Zhang L, Shi Y K, Han X H
Department of Clinical Laboratory, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100021, China.
Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing 100021, China.
Zhonghua Zhong Liu Za Zhi. 2022 Feb 23;44(2):167-172. doi: 10.3760/cma.j.cn112152-20200321-00244.
To investigate the postoperative prognostic factors of non-metastatic colorectal cancer (non-mCRC), and construct a prognostic prediction model. A total of 846 patients with colorectal cancer who were admitted to the Cancer Hospital, Chinese Academy of Medical Sciences from July 1, 2014 to December 31, 2016 were included in the study. There were 314 patients in the metastatic colorectal cancer (mCRC) group and 532 patients in the non-mCRC group. The data of clinical characteristics, preoperative blood routine and common serum tumor markers for CRC tests were collected retrospectively. The disease-free survival time (DFS) data of patients in non-mCRC group were obtained by follow-up. Univariate and multivariate Cox regression analyses were used to clarify the independent risk factors of DFS, and then these factors were included to construct a nomogram prediction model. The concordance index (C index), receiver operating characteristic curve (ROC) and calibration curve were used to evaluate the performance of the model. Platelet/lymphocyte ratio (PLR), neutrophil/lymphocyte ratio (NLR), carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA19-9) and carbohydrate antigen 242 (CA242) in the mCRC group were higher than those of the non-mCRC group, while the lymphocyte/monocyte ratio (LMR) was lower than that of the non-mCRC group (<0.05). ROC analysis showed that the area under curve (AUC) of CEA, CA19-9, CA242, NLR, LMR and PLR for the diagnosis of mCRC were 0.775, 0.716, 0.712, 0.607, 0.591 and 0.556, respectively. Multivariate Cox regression analysis demonstrated that age, perineural invasion, pN stage and preoperative CA242 level were independent risk factors for DFS of non-mCRC patients (<0.05). Based on this, a nomogram prediction model predicting 3 years of DFS for non-mCRC patients was constructed, its C index and AUC for non-CRC prognostic prediction were 0.710 and 0.733, respectively, higher than 0.696 and 0.701 of AJCC 7th edition TNM staging system. The calibration curve of nomogram showed that the predicted DFS rate was consistent with the actual DFS rate. Age, perineural invasion, pN stage and preoperative CA242 level are independent risk factors for 3-year DFS of non-mCRC patients. The nomogram prediction model constructed based on these four indictors has a good predictive performance and may provide prognosis evaluation reference for the patients with non-mCRC.
探讨非转移性结直肠癌(non-mCRC)的术后预后因素,并构建预后预测模型。本研究纳入了2014年7月1日至2016年12月31日在中国医学科学院肿瘤医院收治的846例结直肠癌患者。其中转移性结直肠癌(mCRC)组314例,非mCRC组532例。回顾性收集患者的临床特征、术前血常规及结直肠癌常用血清肿瘤标志物检测数据。通过随访获取非mCRC组患者的无病生存时间(DFS)数据。采用单因素和多因素Cox回归分析明确DFS的独立危险因素,然后纳入这些因素构建列线图预测模型。采用一致性指数(C指数)、受试者工作特征曲线(ROC)和校准曲线评估模型性能。mCRC组的血小板/淋巴细胞比值(PLR)、中性粒细胞/淋巴细胞比值(NLR)、癌胚抗原(CEA)、糖类抗原19-9(CA19-9)和糖类抗原242(CA242)均高于非mCRC组,而淋巴细胞/单核细胞比值(LMR)低于非mCRC组(<0.05)。ROC分析显示,CEA、CA19-9、CA242、NLR、LMR和PLR诊断mCRC的曲线下面积(AUC)分别为0.775、0.716、0.712、0.607、0.591和0.556。多因素Cox回归分析表明,年龄、神经侵犯、pN分期和术前CA242水平是非mCRC患者DFS的独立危险因素(<0.05)。据此构建了预测非mCRC患者3年DFS的列线图预测模型,其用于非CRC预后预测的C指数和AUC分别为0.710和0.733,高于美国癌症联合委员会(AJCC)第7版TNM分期系统的0.696和0.701。列线图的校准曲线显示预测的DFS率与实际DFS率一致。年龄、神经侵犯、pN分期和术前CA242水平是非mCRC患者3年DFS的独立危险因素。基于这四个指标构建的列线图预测模型具有良好的预测性能,可为非mCRC患者提供预后评估参考。